APA (7th ed.) Citation

Schönung, M., Rathmann, S., Ramamoorthy, S., Lebrecht, D., Klingebiel, T., Locatelli, F., . . . Flotho, C. (2025). Assessment of peripheral blood DNA methylation signatures as pharmacodynamic and predictive biomarkers during azacitidine therapy in juvenile myelomonocytic leukaemia: Results of the EWOG-MESRAT study. British journal of haematology, 207(4), . https://doi.org/10.1111/bjh.70046

Chicago Style (17th ed.) Citation

Schönung, Maximilian, et al. "Assessment of Peripheral Blood DNA Methylation Signatures as Pharmacodynamic and Predictive Biomarkers During Azacitidine Therapy in Juvenile Myelomonocytic Leukaemia: Results of the EWOG-MESRAT Study." British Journal of Haematology 207, no. 4 (2025). https://doi.org/10.1111/bjh.70046.

MLA (9th ed.) Citation

Schönung, Maximilian, et al. "Assessment of Peripheral Blood DNA Methylation Signatures as Pharmacodynamic and Predictive Biomarkers During Azacitidine Therapy in Juvenile Myelomonocytic Leukaemia: Results of the EWOG-MESRAT Study." British Journal of Haematology, vol. 207, no. 4, 2025, https://doi.org/10.1111/bjh.70046.